[HTML][HTML] Polymer-and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives
H Han, S Li, M Xu, Y Zhong, W Fan, J Xu, T Zhou… - Advanced Drug Delivery …, 2023 - Elsevier
Ocular diseases seriously affect patients' vision and life quality, with a global morbidity of
over 43 million blindness. However, efficient drug delivery to treat ocular diseases …
over 43 million blindness. However, efficient drug delivery to treat ocular diseases …
VEGF in signaling and disease: beyond discovery and development
The discovery of vascular endothelial-derived growth factor (VEGF) has revolutionized our
understanding of vasculogenesis and angiogenesis during development and physiological …
understanding of vasculogenesis and angiogenesis during development and physiological …
[HTML][HTML] Optical coherence tomography angiography
Optical coherence tomography (OCT) was one of the biggest advances in ophthalmic
imaging. Building on that platform, OCT angiography (OCTA) provides depth resolved …
imaging. Building on that platform, OCT angiography (OCTA) provides depth resolved …
Retinal vascular occlusions
IU Scott, PA Campochiaro, NJ Newman, V Biousse - The Lancet, 2020 - thelancet.com
Acute retinal vascular occlusions are common causes of visual impairment. Although both
retinal artery occlusions and retinal vein occlusions are associated with increased age and …
retinal artery occlusions and retinal vein occlusions are associated with increased age and …
Guidelines for the management of retinal vein occlusion by the European Society of Retina Specialists (EURETINA)
U Schmidt-Erfurth, J Garcia-Arumi, BS Gerendas… - …, 2019 - karger.com
The high prevalence of cardiovascular disease particularly in the elderly population is
associated with retinal vascular disease. Retinal vein occlusions represent severe …
associated with retinal vascular disease. Retinal vein occlusions represent severe …
Efficacy and tolerability of bevacizumab in patients with severe Covid-19
J Pang, F Xu, G Aondio, Y Li, A Fumagalli, M Lu… - Nature …, 2021 - nature.com
On the basis of Covid-19-induced pulmonary pathological and vascular changes, we
hypothesize that the anti-vascular endothelial growth factor (VEGF) drug bevacizumab might …
hypothesize that the anti-vascular endothelial growth factor (VEGF) drug bevacizumab might …
[HTML][HTML] VEGFR1 signaling in retinal angiogenesis and microinflammation
Five vascular endothelial growth factor receptor (VEGFR) ligands (VEGF-A,-B,–C,-D, and
placental growth factor [PlGF]) constitute the VEGF family. VEGF-A binds VEGF receptors 1 …
placental growth factor [PlGF]) constitute the VEGF family. VEGF-A binds VEGF receptors 1 …
Retinal vein occlusion review
M Ip, A Hendrick - The Asia-Pacific Journal of Ophthalmology, 2018 - journals.lww.com
Retinal Vein Occlusion Review : The Asia-Pacific Journal of Ophthalmology Retinal Vein
Occlusion Review : The Asia-Pacific Journal of Ophthalmology Log in or Register Get new issue …
Occlusion Review : The Asia-Pacific Journal of Ophthalmology Log in or Register Get new issue …
Clinical effectiveness of intravitreal therapy with ranibizumab vs aflibercept vs bevacizumab for macular edema secondary to central retinal vein occlusion: a …
P Hykin, AT Prevost, JC Vasconcelos… - JAMA …, 2019 - jamanetwork.com
Importance The comparative clinical effectiveness of ranibizumab, aflibercept, and
bevacizumab for the management of macular edema due to central retinal vein occlusion …
bevacizumab for the management of macular edema due to central retinal vein occlusion …
Macrophages in close proximity to the vitreoretinal interface are potential biomarkers of inflammation during retinal vascular disease
A Rajesh, S Droho, JA Lavine - Journal of neuroinflammation, 2022 - Springer
Background Diabetic retinopathy and retinal vein occlusion are vision threatening retinal
vascular diseases. Current first-line therapy targets the vascular component, but many …
vascular diseases. Current first-line therapy targets the vascular component, but many …